706 related articles for article (PubMed ID: 23327604)
1. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
[TBL] [Abstract][Full Text] [Related]
2. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
3. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral.
Döri F; Nikolidakis D; Húszár T; Arweiler NB; Gera I; Sculean A
J Clin Periodontol; 2008 Jan; 35(1):44-50. PubMed ID: 18034853
[TBL] [Abstract][Full Text] [Related]
4. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
[TBL] [Abstract][Full Text] [Related]
5. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
Yilmaz S; Cakar G; Yildirim B; Sculean A
J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
[TBL] [Abstract][Full Text] [Related]
6. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.
Pietruska M; Pietruski J; Nagy K; Brecx M; Arweiler NB; Sculean A
Clin Oral Investig; 2012 Aug; 16(4):1191-7. PubMed ID: 21881869
[TBL] [Abstract][Full Text] [Related]
7. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
[TBL] [Abstract][Full Text] [Related]
8. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.
Döri F; Arweiler N; Gera I; Sculean A
J Periodontol; 2005 Dec; 76(12):2236-43. PubMed ID: 16332235
[TBL] [Abstract][Full Text] [Related]
10. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans.
Hoidal MJ; Grimard BA; Mills MP; Schoolfield JD; Mellonig JT; Mealey BL
J Periodontol; 2008 Dec; 79(12):2273-80. PubMed ID: 19053917
[TBL] [Abstract][Full Text] [Related]
12. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
[TBL] [Abstract][Full Text] [Related]
13. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
Gurinsky BS; Mills MP; Mellonig JT
J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
[TBL] [Abstract][Full Text] [Related]
17. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
[TBL] [Abstract][Full Text] [Related]
18. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.
Sculean A; Kiss A; Miliauskaite A; Schwarz F; Arweiler NB; Hannig M
J Clin Periodontol; 2008 Sep; 35(9):817-24. PubMed ID: 18647201
[TBL] [Abstract][Full Text] [Related]
19. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Arweiler NB; Gera I; Sculean A
J Periodontol; 2007 Jun; 78(6):983-90. PubMed ID: 17539709
[TBL] [Abstract][Full Text] [Related]
20. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
